FIRST AIRED: August 4, 2017

Nice work! Enjoy the show!


You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!

We've got more news

Get our editor’s daily email summary of what’s going on in the world.

US Edition
Intl. Edition
Replay Program
More Info

COMING UP:Share Opener Variant 3



>> The verdict as it now stands->> Martin Shkreli, infamous for raising the price of a drug used by AIDS patients by 5,000% convicted on Friday of three counts of securities fraud.>> We're delighted in many ways with this verdict.>> His team was delighted because the outspoken executive was facing charges on eight counts.
He was convicted on two counts of securities fraud and one count of conspiracy and those could still land him in prison for up to 20 years. The boyish 34 year-old was accused of lying to investors, losing their money, and paying them back with cash and stock from his old drug company, Retrophin.
Shkreli and his lawyer emphasized that none of the investors actually lost money and chalked up the trial as a witch hunt.>> This was a witch trial of epic proportions. And maybe they found one or two broomsticks, but at the end of the day we've been acquitted of the most important charges of this case.
>> Before the trial, Shkreli sparked outrage when as CEO of Turing Pharmaceuticals, he raised the price of the drug Daraprim by 5,000%.>> On the advice of counsel->> The ensuing controversy and his combative attitude earned him the nickname Pharmabro.>> In self-incrimination, and respectfully decline to answer your question.